The Effect of Capsaicin-Phenylephrine-Caffeine Formulation on Aborting Tilt Induced Syncope in Patients With a History of Vasovagal Syncope

Who is this study for? Patients with Vasovagal Syncope
What treatments are being studied? Tilt Table Test
Status: Recruiting
Location: See location...
Intervention Type: Drug, Diagnostic Test
Study Type: Interventional
Study Phase: Phase 2
SUMMARY

Syncope is defined as transient loss of consciousness associated with inability to maintain postural tone with rapid and spontaneous recovery. The purpose of this study is to assess the effects of sublingual administration of a new medication called CPC on tilt-induced syncope in patients with a history of vasovagal syncope (VVS). 132 participants will be enrolled at the University of Wisconsin - Madison. Each participant will be in the study for 1 day.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 50
Healthy Volunteers: No
View:

• Established diagnosis of typical vasovagal syncope

• Age 18-50 years

Locations
United States
Wisconsin
University of Wisconsin- Madsion
Recruiting
Madison
Contact Information
Primary
Mohamed H Hamdan, MD
mhamdan@medicine.wisc.edu
608-263-1532
Backup
Cassondra A Vander Ark, MS
cav@medicine.wisc.edu
608-265-0612
Time Frame
Start Date: July 20, 2021
Estimated Completion Date: December 31, 2023
Participants
Target number of participants: 132
Treatments
Experimental: CPC Adminstration
Single dose of CPC will be given during tilt table test
Placebo Comparator: Placebo Adminstration
Single dose of Placebo will be given during tilt table test
Sponsors
Leads: University of Wisconsin, Madison

This content was sourced from clinicaltrials.gov

Similar Clinical Trials